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Merkel cell carcinoma (MCC) and small cell
lung cancer (SCLC) share quite distinct
similarities such as almost undistinguishable
histological presentation (fig 1a,b) and
highly aggressive biological behaviour with
high rates of metastasis and poor survival
rates.1 2 While tobacco smoking and genetic
susceptibility have been identified as risk
factors for SCLC,3 4 sun exposure and
immunosuppression are the main risk fac-
tors for MCC.1 In January 2008, a new virus,
called Merkel cell polyomavirus (MCPyV),
was desribed by Feng et al as a likely
causative agent of MCC, proving monoclo-
nal MCPyV–genome integration in 8 of 10
MCCs.5 Since then these findings have been
reproduced by several groups.6 7
Because SCLC and MCC share obvious
similarities in histological presentation,
Wetzels et al recently published the first
report looking for MCPyV prevalence in
SCLC.8 They investigated a small cohort of
10 patients with SCLC, finding no prevalence
for MCPyV. We performed a molecular
pathology study in a relatively large cohort
of 31 patients (36 samples) analysing the
presence of MCPyV DNA by PCR and
chemiluminescence Southern blot hybridiza-
tion of PCR products. These data are the first
to test the findings of Wetzels and colleagues.
Based on the DNA sequences published by
Feng et al, we designed two sets of primers in
order to test the formalin-fixed and paraffin-
embedded (FFPE) tissues for the presence of
specific MCPyV DNA. After DNA extraction
from FFPE tissues, PCR amplification using
these primer combinations resulted in
a 138 bp product (MCV138 forward:
59-GGTTAGAGATGCTGGAAATGACC-39;
reverse: 59-CAAATAAGCAGCAGTACCAGGC-39)
and a 191 bp product (MCV191 forward,
59-CCACTTTATTATCTTAGCCCAT-39; and
reverse, 59-TCCTTTTGGCTAGAACAGTGTC-39)
targeting the large and small T-antigen
region of MCPyV (isolate MCC-Mpt-LS2).
Results were confirmed by chemilumenis-
cence Southern blotting with specific
probes for MCV138 and MCV191, omit-
ting primer sequences and carrying a 59
digoxigenin label (DIG-MCV138 forward,
59-GTAAGAAGTTTAAGAAGCACCTAG-39;
and DIG-MCV191 forward, 59-GATCTCG-
CCTCAAACCTCACAAG-39). DNA quality
was confirmed by b-globin PCR using the
GH20 (59-GAAGAGCCAAGGACAGGTAC-39)
and PCO4 (59-CAACTTCATCCACGTTCACC-39)
primer set.
Of the 36 SCLC specimens, 35 revealed a b-
globin PCR product. These 35 specimens were
from 30 patients (13 women and 17 men,
clinically not differentiated in limited and
extensive disease; 2 patients with three
samples each and 1 patient with two sam-
ples). Their mean (SD) age was 67.9 (8.6)
years. MCPyV sequences were detected in 2
of 30 patients (7.5%), specifically in three of
35 samples (two of these three samples are
from 1 patient, both positive for MCV138
(fig 1c,d) and the remaining sample was
positive for MCV191). The PCR-negative
controls, containing all other PCR compo-
nents and water instead of DNA, were
constantly negative in all experiments.
Based on the data presented here, it is
unlikely that MCPyV plays a significant
pathogenetic role in SCLC; nevertheless a
supplemental role as cofactor in the patho-
genesis of SCLC cannot be ruled out
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completely. Rather we assume that a
MCPyV prevalence of 7.5% represents the
MCPyV prevalence in the general popula-
tion. We found almost identical numbers for
the MCPyV prevalence in non-MCC
tumours of sun-exposed skin.7 More data
will be needed to prove this assumption.
Nevertheless, the morphological similarities
of both tumours are striking and will keep
the intriguing idea of a possibly (polyoma-)
virus-associated pathogenesis in mind.
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Figure 1 Histological features of (a) Merkel cell carcinoma (MCC; H&E staining, 6400) and
(b) small cell lung cancer (SCLC; H&E staining, 6400). Both tumours are composed of highly
mitotic, small basophilic tumour cells. (c) Electropherogram of a 1.5% agarose gel for MCV138 in
eight patients with SCLC (three samples from patient 3) including a positive (+), and negative
control (–) and an HaeIII size ladder (L). (d) Corresponding Southern blot. Samples 3b and 3c display
specific PCR products, confirmed by Southern blot analysis.
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